Back to Journals » Drug Design, Development and Therapy » Volume 13

A brief report of toxicity end points of HER2 vaccines for the treatment of patients with HER2+ breast cancer

Total article views   HTML views PDF downloads Totals
6,855 Dovepress* 5,223+ 1,165 6,388
PubMed Central* 1,632 202 1,834
Totals 6,855 1,367 8,222
*Since 14 January 2019

View citations on PubMed Central and Google Scholar